We read with interest the article by Afessa and colleagues (October 2001) 1 about obstetric patients needing critical care. We would like to comment on our experience after a retrospective study developed in a tertiary hospital, from 1991 to 1998. During this period, out of 49,717 delivery patients, we admitted 149 patients (0.3%) to the ICU.
quite low compared with those described by Platteau et al 2 (21%), Collop and Sahn 3 (20% and 35% respectively), Monaco et al 4 (18% and 12% respectively), or Kilpatrick and Matthay 5 (25%). This is why we were surprised by the even lower incidence found in the Afessa study.
In conclusion and after reading a recent article by Waterstone et al, 6 we think future studies should try to estimate the predictor factors of severe obstetric morbidity, in order to improve prenatal care, perinatal management, and anesthetic procedures. With reliable predictor factors, we could reduce the number of obstetric patients who require critical care, and we could lower the rates of maternal and fetal morbidity and mortality. To the Editor:
In the experience related by Olarra et al, 0.3% of the obstetric patients were admitted to the ICU. This rate of ICU admission is similar to the rate reported in the literature. The authors mentioned some differences between their findings and ours. 1 We are not surprised by these differences, because variations are likely to exist between our hospital and theirs with regard to patient mix, ICU admission criteria, and hospital settings. Similar to the observation by Olarra et al, others have reported hypertensive diseases of pregnancy to be the most common reason for ICU admission. 2, 3 Like the study by Lapinsky et al, 4 respiratory failure and hemodynamic instability were responsible for ICU admission of 80% of the patients in our study. 1 enzymes, and low platelet count (HELLP) were present in 33 of our patients. 1 Although these 33 patients may have had coexistent hypertension, that condition was the reason for ICU admission in only 5 patients. Our obstetric unit has equipment and staff to provide care to noncomplicated cases of hypertension without ICU admission, explaining this observation. Although there was no significant difference in the incidence of pulmonary edema between patients who did and did not undergo emergent cesarean section, pulmonary edema was the most common reason for ICU admission in our study. 1 A large, earlier study had also shown that pulmonary edema is a common occurrence in obstetric patients admitted to ICU. 5 We are surprised by the absence of any case of pulmonary edema in the study by Olarra et al.
The reported mortality rate of obstetric patients admitted to ICU ranges between 0% and 36%. 1 The mortality rate reported by Olarra et al is within this range. Heterogeneity of the patient population and differences in disease severity may account for the differences in the reported mortality rates of critically ill obstetric patients. We agree with Olarra et al on the need for future studies to identify the risk factors for obstetric-associated critical illness, in order to decrease the associated morbidity and mortality.
Bekele Afessa, MD, FCCP Mayo Clinic and Foundation
Rochester, MN 
Strength of Evidence for LowMolecular-Weight Heparin
To the Editor:
In the Sixth ACCP Consensus Conference on Antithrombotic Therapy, Geerts et al 1 recommend (evidence 1A) the use of low-molecular-weight-heparin (LMWH) for prevention of venous thromboembolism in patients with ischemic stroke and impaired mobility. As reported, the recommendation is based on the results of three randomized control trials; one of those trials compared LMWH with unfractioned heparin and yielded no evidence on the disadvantages of nonprevention. The results of the two smaller-sized placebo-controlled trials are in disagreement. We think that this recommendation lacked a clear-cut connection to the evidence.
In support of our opinion, a meta-analysis by Bath et al 2 assessed the efficacy and safety of treatment with LWMH in patients with acute ischemic stroke. 
